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Abstract
Background Lymphatic drainage to multiple basins (MLBD) is frequently observed in patients with primary
melanoma located in the trunk. Conflicting data regarding the prognostic impact of MLBD are reported.
Objective and methods We reviewed our case series of 352 patients with trunk melanoma to evaluate the pattern
of basin drainage and to analyse whether different basin drainages may have different significance in negative
sentinel lymph node (SLN) patients. The presence of single ⁄multiple basin drainage, the status of SLN, the presence
of melanoma regression, Breslow thickness, ulceration and type of melanoma were recorded for each patients and
correlated to Disease Free Survival (DFS) and Overall Survival (OS).
Results MLBD occurred in 77 patients (21.9%) and single basin lymphatic drainage (SLBD) occurred in 275
patients (79.1%). The presence of metastases in SLN was not significantly different in patients with MLBD compared
to those with SLBD (26% vs. 19.6%). No differences in OS and DFS were found in SLBD ⁄MLBD independently from
SLN status. However DFS was higher in patients with MLBD and negative SLN (P = 0.0001), in addition, in patients
with negative SLN and SLBD disease recurrence was 19% while was only 7% in patients with negative SLN
obtained from MLBD (P = 0.03). Multivariate analysis showed that Breslow thickness <2 mm, MLBD pattern and
regression of melanoma were favourable variables for DFS of patients with negative SLN.
Conclusions An accurate study of the drainage basin and of all the SLNs obtained from MLBD is recommended
because of the impact in prognosis of melanoma of the trunk.
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Introduction
Breslow thickness, ulceration and mitotic rate are well-recognized
prognostic features of cutaneous melanoma incorporated into the
current American Joint Committee on Cancer (AJCC) staging sys-
tem.1 After the introduction of lymphoscintigraphy and sentinel
lymph node (SLN) biopsy, the histologic status of the SLN has
been found to be the strongest prognostic factor for survival and
recurrence in patients with primary melanoma and clinically nega-
tive lymph nodes.2,3
The location of the primary tumour has been considered as
another prognostic factor. In particular numerous studies docu-
mented a worse prognosis in patients with primary melanomas of
the trunk when compared with those located of the extremities.4–6
The truncal location is characterised by lymphatic drainage to
multiple basins (MLBD) in about one third of cases.7 Conflicting
data regarding the prognostic impact of MLBD are reported. Some
authors showed that MLBD for truncal melanoma was associated
with an increased risk of nodal metastases7 or worse survival.8 On
the other hand, other studies did not confirm these findings,9,10
suggesting that this phenomenon was only related to an overlap-
ping drainage from the area of skin injected.10
Given the limited number of studies evaluating multiple drain-
ages, its association with recurrence and the controversial results
on survival, we retrospectively reviewed our case series of truncal
melanomas with the aim of evaluating the prognostic impact of
MLBD on Disease Free Survival (DFS) and Overall Survival (OS).1Both authors contributed equally.
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Methods
Patient population and follow up
A total of 815 consecutive patients with primary cutaneous mela-
noma underwent lymphatic mapping and SLN biopsy from May
1998 to July 2011 at our institutions. Among them 352 (43.2%)
patients had a melanoma of the trunk.
Sentinel lymph node biopsy (SLNB) criteria were: Breslow
thickness ‡1 mm or Breslow thickness <1 mm and at least one of
the following histopathologic features: presence of regression,
ulceration and ⁄or Clark level IV–V and ⁄or mitotic rate ‡1; no
clinical or radiological evidence of regional and ⁄or distant metas-
tases. The follow up was performed according to the guidelines in
use at the time of diagnosis11,12 and extended until July 2011.
Sentinel node biopsy
Sentinel lymph node (SLN) biopsy was performed as previously
described by Morton et al.13 The SLNs were detected using a stan-
dardised preoperative protocol that included both lymphoscintig-
raphy and intradermal injection of patent blue dye around surgical
scar. All single or multiple basins identified by lymphoscintigrafy
were dissected. All radiolabeled lymph nodes and ⁄or those which
appeared blue stained were considered to be SLNs and were excised.
Sentinel lymph nodes (SLN) were immediately fixed in buffered
formalin, bisected along the long axis of the ilar region and
embedded in one or more paraffin blocks depending on SLN size.
Sections were cut and immunostained with S-100 and HMB45
according to the European Organisation for Research and Treat-
ment of Cancer (EORTC) recommendations14 for working up of
SLN of melanoma.
The slides were examined independently by two investigators
(LM and AS) both blinded to the clinico-pathological data.
Statistical analysis
Statistical analyses were performed using the Stata 11.0 Statistical
Software. Both parametric and non-parametric tests were used;
only ‘‘P’’ values of parametric tests were reported, as the results of
the two tests were similar. Univariate logistic regression was used
to test for the significance of the predictor variables. For all
patients, DFS was calculated from the surgical excision of SLN to
the date of first disease relapse, OS was calculated from the surgi-
cal excision of SLN to the date of death or last check-up. Survival
estimates were derived by the Kaplan–Meier method and the sta-
tistical comparison was done by the log-rank test. Univariate and
multivariate analyses were carried out to evaluate the influence of
different variables on DFS and OS.
Results
Clinico-pathologic characteristics and associated SLN
findings
The clinico-pathologic characteristics are listed in Table 1.
Almost two thirds of the patients were male (245 ⁄ 352, 69.6%).
In the majority of patients, the SLN was identified in the axillary
basin (80.7%). Overall 74 patients out of 352 (21%) had a positive
SLN biopsy result. No differences in the SLN status were found
according to the basin site.
A complete lymph node dissection (CLND) was performed in
all patients with positive SLN, 13 out of 74 showed lymph node
metastases (17.6%).
Drainages to more than one lymphatic basin are identified
in 77 patients (21.9%). The identification of MLBD was signif-
icantly associated with female gender (29% vs. 18.8% in males;
P = 0.03). Age, Breslow thickness, Clark, histological character-
istics, front ⁄back site of the primary melanoma and ulceration
demonstrated no significant association with the likelihood of
drainage to more than one basin. Patients with MLBD did
not show a higher incidence of positive SLN than those with
single nodal basin drainage (SLBD) (26% vs. 19.6%, respec-
tively).
Association of lymphatic basin drainage pattern with
DFS and OS in all patients
The median follow-up time calculated from the date of surgical
excision of SLN to the last contact date was 3.4 years (range
6 months–11.3 years). Out of 352 patients, 72 developed a dis-
ease recurrence (20.5%) and 57 patients (16.2%) died during the
follow up.
No significant differences in DFS and OS were found in the two
categories SLBD ⁄MLBD (Fig. 1a,b) independently from the status
of SLN.
As expected patients with SLN positive presented a worse prog-
nosis. DFS and OS were influenced by both the number of drain-
age basins and SLN results, as shown in Fig. 2a,b. In particular the
DFS was significantly more favourable in patients with negative
MLBD as compared with that of other groups. In fact in patients
without metastases 5-years DFS was 89.6% and 80.7% in MLBD
and SLBD respectively; in SLBD positive DFS was 65.5% while it
was of 61.2% in patients with MLBD and at least 1 positive basin
or of 60% in patients with both positive basins respectively
(P = 0.0001)
Similar results were observed in OS: in patients with SLN nega-
tive 5-years OS was 88.9% in MLBD and 82.1% in SLBD. On the
contrary OS was of 63% in SLBD positive patient, 52.7% in cases
with MLBD with at least 1 positive basin and 53.3% in MLBD
with both positive basins (P < 0.0001).
Association of lymphatic basin drainage pattern with
DFS and OS in patients with negative SLN
Features of patients with single or multiple drainage and negative
SLN are reported in Table 2. A more frequent identification of
MLBD was confirmed to be associated with female gender (28.2%
F vs. 17.1% M). Age, Breslow thickness, Clark, histological charac-
teristics, regression and ulceration demonstrated no significant
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association with the likelihood of drainage to more than one basin
in SLN negative patients. A significantly higher percentage of dis-
ease recurrence characterized the SLBD patients (19%) as com-
pared to the MLBD ones (7%, P = 0.03).
The prognostic relevance of MLBD in SLN negative patients
was analysed by multivariate Cox regression. MLBD maintained a
significant favourable prognostic role on DFS as independent fac-
tor (HR: 0.28) together with the presence of regression and low
Breslow thickness (Table 3). On the other hand, no difference in
OS was found between SLBD and MLBD in SLN negative patients.
Thus, taking into consideration the significant results from the
multivariate analysis we combined the three parameters that main-
tained a protective role on DFS.
Patients with negative MLBD, presence of regression and Bre-
slow thickness <2 mm (20 out of 77 MLBD), presented a signifi-
cantly longer DFS (Fig. 3) than patients without the 3 favourable
parameters (10-years DFS: 100% vs. 46.6% respectively).
Discussion
This study provides an analysis of the prognostic impact of MLBD
on DFS and OS in patients with diagnosis of primary truncal mel-
anoma stratified on the basis of SLN status.
The presence of a single or multiple basin drainage does not
affect significantly the disease course in patients with metastatic
SLN. The new finding we report is that patients with negative SNL
obtained from MLBD show a significantly better prognosis than
patients with negative SLN obtained from SLBD. Specifically this
result together with the presence of regression and Breslow thick-
ness <2 mm identifies a subgroup of patients with lower risk of
progression.
We focused our analysis on trunk melanoma which is indeed
responsible for the majority of MLBD, to be able to collect a
homogeneous patients’ cohort and thus avoiding biases related to
the controversial prognostic significance of melanoma localisa-
tion.4–6 Despite the trunk is the principal site of melanoma in
male,4,5 MLBD was most frequent in females. This correlation was
maintained even when we considered only negative SLN patients.
Mc Hugh et al.10 reported that gender was not associated with
drainage typology, whereas other authors presented a population
with a male prevalence in the MLBD group.8
The percentage of patients with truncal melanoma and evidence
at preoperative lympho-scintigraphy of MLBD ranges widely
between 17% and 46% according to different study series.7–9,15 In
our analysis 21.9% of 352 truncal melanoma patients had MLBD.
The prognostic relevance of MLBD is still a matter of contro-
versy. Some studies did not find any relationship between SLBD
and MLBD and DFS or OS.9,10,15 Porter et al.7 reported that
MLBD is associated with an increased risk of SLN metastases. Our
Table 1 Clinical and pathologic characteristics of the 352 patient with melanoma of the trunk
All patients
(n = 352)
SLBD
(n = 275)
MLBD
(n = 77) P
Gender Male 245 (69.6%) 199 46 0.03
Female 107 (30.4%) 76 31
Age 56 (16–86) 56 (16–86) 55 (22–78) NS
Breslow 2.34 ± 1.97 2.37 ± 1.86 2.27 ± 2.36 NS
Trunk site Front 122 97 25 NS
Back 230 178 52
Clark I 1 (0.3%) 1 0 NS
II 27 (7.7%) 20 7
III 170 (48.3%) 129 41
IV 143 (40.6%) 117 26
V 11 (3.1%) 8 3
Histological characteristic SSM 268 (76.1%) 208 60 NS
Nodular 66 (18.8%) 54 12
Other 18 (5.1%) 13 5
Ulceration Absent 261 (74.2%) 204 57 NS
Present 91 (25.8%) 71 20
SLN Negative 278 (74.4%) 221 57 NS
Positive 74 (26.6%) 54 20
SLN basin Cervical 6 (1.7%) 5 1 NS
Axillary 284 (80.7%) 228 56
Inguinal 48 (13.6%) 42 6
Mixed 14 (4%) – 14
MLBD, multiple lymphatic basin drainage; NS, not significant; SLBD, single lymphatic basin drainage; SLN, sentinel lymph node; SSM, superficial
spreading melanoma.
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study did not confirm these results as no differences were found
in numbers of SLN metastases between SLBD and MLBD patients
(19.6% vs. 26%, respectively). Similar results were already reported
by others.8–10 Porter et al.7 and Jimenez et al.8 reported that
MLBD patients have a less favourable prognosis than the SLBD
ones, independently from the SLN status. The design of our study
took into consideration the prognostic value of the SLN status
within the SLBD and MLBD groups of patients (i.e. positive and
negative SLN). The discrepancy as compared to the study by Jime-
nez et al.8 could also be explained by a smaller cohort of patients
and a shorter median follow-up (27 months vs. 42 months in our
series). Pinˇero et al.16 and Wall et al.17 confirmed a worse
outcome of MLBD in a retrospective cohort study with compara-
ble follow-up, but they studied primary melanomas of both trunk
and extremities with or without neck site respectively. MLBD
involvement might identify a more aggressive behaviour and
higher metastatic potential. Different alternative speculations may
be considered for example development of collateral lymphatic
vessels as a result of local tumour growth, congestion of the pri-
mary drainage pathway by tumour cells, postoperative develop-
ment of new lymphatic channels around the original site of the
tumour or a combination of these. The discrepancies in literature
results could be related to the different technique for SLN identifi-
cation as well as to a heterogeneous patients’ population or differ-
ent anatomic pattern of drainage. On the contrary in our
experience the finding of a negative SLN in MDLB was associated
with a favourable prognosis.
The association with regression and Breslow thickness strength-
ened this observation. Regression traditionally it has been consid-
ered as a marker of poor prognosis, mainly in thin melanomas, as
it cannot be ruled out that the initial thickness of the melanoma
in the area of regression might have been superior to that sug-
gested by the Breslow depth of the remaining tumour. On the
contrary recent data reported that the presence of regression was
associated with a lower likelihood of a positive SLN and even bet-
ter clinical outcome.6,18–20 Probably regression may be considered
as an indicator of an immune response of the host against the pri-
mary tumour and, consequentially, it might have a certain protec-
(a)
(b)
Figure 2 Disease Free Survival (a) and Overall Survival (b) of
patients depending on the type of basin drainage and the status
of Sentinel Lymph Node (SLN). Survival analysis on patients
stratified or number of drainage and result of SLN (a) DFS;
(b) OS (a = SLN negative MLBD, b = SLN negative SLBD,
c = MLBD with at least 1 positive basin, d = SLN positive SLBD,
e = SLN positive MLBD).
(a)
(b)
Figure 1 Disease Free Survival (a) and Overall Survival (b) of
patients depending on the type of basin drainage independently
from the status of Sentinel Lymph Node (a = MLBD, multiple
lymphatic basin drainage; b = SLBD, single lymphatic basin
drainage).
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tive effect. Although the biological pathways related to the favour-
able prognostic relevance of negative MLBD are not clear at pres-
ent, it could be speculated that this phenomenon could be
explained from an immunological point of view. Indeed, from one
side, the association with regression reflects a potential capacity of
the immune system to recognize and therefore enhance the
immune response against tumour; from the other side, the multi-
ple anatomic drainage could allow a better contact between
tumour cells and the immune surveillance system, in according to
recent findings.6,18–20 Kaur et al.20 demonstrated that primary
regression is a favourable prognostic feature in melanoma patients
and is not associated to a higher risk of metastatic SLN. More
recently, Ma et al.19 showed that melanoma regression and pres-
ence of dendritic cell increase in the primary lesion are associated
to a significantly decreased incidence of SLN involvement. This
theory is supported by the evidence of relevant amounts of regula-
tory T cells in metastatic SLNs when compared to the negative
ones; this event potentially reveals a down-regulation of antitu-
mour immune responses.
From a clinical point of view, our data show that the presence
of negative MLBD may be a potential new parameter for the iden-
tification of patients with a more favourable disease course, thus
an accurate study of the drainage basin and of all the SLNs
obtained is recommended.
References
1 Balch CM, Gershenwald JE, Soong SJ et al. Final version of 2009 AJCC
melanoma staging and classification. J Clin Oncol 2009; 27: 6199–6206.
2 Gershenwald JE, Thompson W, Mansfield PF et al. Multi-institutional
melanoma lymphatic mapping experience: the prognostic value of senti-
nel lymph node status in 612 stage I or II melanoma patients. J Clin
Oncol 1999; 17: 1–8.
3 Morton DL, Thompson JF, Cochran AJ et al. Sentinel-node biopsy or
nodal observation in melanoma. N Engl J Med 2006; 355: 1307–1317.
4 Garbe C, Buttner P, Bertz J et al. Primary cutaneous melanoma. Prog-
nostic classification of anatomic location. Cancer 1995; 75: 2492–2498.
5 Balch CM, Soong S, Ross MI et al. Long-term results of a multi-institu-
tional randomized trial comparing prognostic factors and surgical
results for intermediate thickness melanomas (1.0 to 4.0 mm). Inter-
group Melanoma Surgical Trial. Ann Surg Oncol 2000; 7: 87–97.
6 Savoia P, Fava P, Caliendo V et al. Disease progression in melanoma
patients with negative sentinel lymph node: does false-negative speci-
mens entirely account for this phenomenon? J Eur Acad Dermatol Vene-
reol 2012; 26: 242–248.
7 Porter GA, Ross MI, Berman RS et al. Significance of multiple nodal
basin drainage in truncal melanoma patients undergoing sentinel lymph
node biopsy. Ann Surg Oncol 2000; 7: 256–261.
8 Jimenez RE, Panageas K, Busam KJ et al. Prognostic implications of
multiple lymphatic basin drainage in patients with truncal melanoma.
J Clin Oncol 2005; 23: 518–524.
Table 2 Clinical and pathologic characteristics of patients with
melanoma of the trunk and negative SLN
Variable SLBD (n = 221) MLBD (n = 57) P
Gender M 160 33 0.034
F 61 24
Age 57 (16–78) 53 (22–78) NS
Breslow 2.18 ± 1.80 2.03 ± 2.42
Clark I 1 0 NS
II 20 5
III 113 35
IV 82 15
V 5 2
Histological
characteristic
SSM 166 44 NS
Nodular 42 9
Other 13 4
Ulceration Absent 166 44 NS
Present 55 13
Regression Absent 143 35 NS
Present 78 22
Status DF 179 53 0.030
PD 42 4
Site of
progression
Regional 19 2 NS
Distant 23 2
DF, disease free; F, female; M, male; MLBD, multiple lymphatic basin
drainage; NS, not significant; PD, progression disease;SLBD, single lym-
phatic basin drainage; SSM, superficial spreading melanoma.
Table 3 Multivariate Cox regression in patients with melanoma
of the trunk and SLN negative. Significant values are highlighted
in bold
DFS HR SE Z P > |z| 95% IC
Age 1.00 0.01 0.44 0.660 0.98 1.02
Gender 0.88 0.31 )0.36 0.717 0.43 1.77
Breslow 1.31 0.09 3.89 0.000 1.14 1.50
Ulceration 1.05 0.44 0.12 0.906 0.46 2.38
Regression 0.27 0.14 )2.61 0.009 0.10 0.73
Multiple drainage 0.28 0.16 )2.24 0.025 0.09 0.85
Nodular histotype 0.71 0.28 )0.85 0.395 0.33 1.55
DFS, disease free survival; HR, hazard rate; IC, interval confidence SE,
standard error.
Figure 3 DFS analysis on patients stratified depending on the
presence of: negative SLN in MLBD, regression and Breslow
thickness <2 mm of primary. (a = all three protective parameters,
b = two protective parameters, c = only one protective parame-
ters, d = no protective parameters).
ª 2012 The Authors
JEADV 2013, 27, 1132–1137 Journal of the European Academy of Dermatology and Venereology ª 2012 European Academy of Dermatology and Venereology
1136 Ribero et al.
9 Jacobs IA, Chang CK, Salti GI. Significance of dual-basin drainage in
patients with truncal melanoma undergoing sentinel lymph node
biopsy. J Am Acad Dermatol 2003; 49: 615–619.
10 McHugh JB, Su L, Griffith KA et al. Significance of multiple lymphatic
basin drainage in truncal melanoma patients undergoing sentinel lymph
node biopsy. Ann Surg Oncol 2006; 13: 1216–1223.
11 Bernengo MG, Quaglino P, Cappello N et al. Time course and pattern
of first relapse in stage I–II primary cutaneous melanoma: a multivari-
ate analysis of disease-free survival in 3,174 patients followed-up at the
Turin Melanoma Centre from 1975 to 2004. G Ital Dermatol Venereol
2005; 140: 191–200.
12 Quaglino P, Borgognoni L, Bottoni U et al. Italian guidelines for stag-
ing and follow-up of stage I–II cutaneous melanoma patients. G It Der-
matol Venereol 2007; 142: 41–47.
13 Morton DL, Wen DR, Wong JH et al. Technical details of intraopera-
tive lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:
392–399.
14 Cook MG, Green MA, Anderson B et al. The development of optimal
pathological assessment of sentinel lymph nodes for melanoma. J Pathol
2003; 200: 314–319.
15 Federico AC, Chagpar AB, Ross MI et al. Effect of multiple-nodal basin
drainage on cutaneous melanoma. Arch Surg 2008; 143: 632–637.
16 Pin˜ero A, de Torre C, Martı´nez-Escribano J et al. Multiple lymphatic
basin drainage from cutaneous melanoma as a prognostic factor. World
J Surg 2012; 36: 579–585.
17 Wall JK, Florero M, Accortt NA et al. Impact of multiple lymphatic
channel drainage to a single nodal basin on outcomes in melanoma.
Arch Surg 2007; 142: 753–757.
18 White RL Jr, Ayers GD, Stell VH et al. Factors predictive of the status
of sentinel lymph nodes in melanoma patients from a large multicenter
database. Ann Surg Oncol 2011; 18: 3593–3600.
19 Ma MW, Medicherla RC, Qian M et al. Immune response in mela-
noma: an in-depth analysis of the primary tumor and corresponding
sentinel lymph node. Mod Pathol 2012; 25: 1000–1010.
20 Kaur C, Thomas RJ, Desai N et al. The correlation of regression in pri-
mary melanoma with sentinel lymph node status. J Clin Pathol 2008;
61: 297–300.
ª 2012 The Authors
JEADV 2013, 27, 1132–1137 Journal of the European Academy of Dermatology and Venereology ª 2012 European Academy of Dermatology and Venereology
Prognostic relevance of MLBD in trunk melanoma 1137
